4.7 Review

Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients with Advanced Cancer: A Double-Edged Sword?

Journal

Publisher

MDPI
DOI: 10.3390/ijms20092194

Keywords

graft rejection; immunotherapy; PD-1 inhibitor; renal transplant

Ask authors/readers for more resources

Given advancements in cancer immunity, cancer treatment has gained breakthrough developments. Immune checkpoint inhibitors, such as programmed cell death 1 (PD-1) inhibitors, are the most promising drugs in the field and have been approved to treat various types of cancer, such as metastatic melanoma, head and neck squamous cell carcinoma, and urothelial carcinoma. However, whether PD-1 inhibitors should be administered to renal transplant patients with advanced cancer remains unclear because the T-cells produced after administration of these inhibitors act against not only tumor antigens but also donor alloantigens. Thus, the use of PD-1 inhibitors in kidney-transplanted patients with advanced cancer is limited on account of the high risk of graft failure due to acute rejection. Hence, finding optimal treatment regimens to enhance the tumor-specific T-cell response and decrease T-cell-mediated alloreactivity after administration of a PD-1 inhibitor is necessary. Thus far, no recommendations for the use of PD-1 inhibitors to treat cancer in renal transplant patients are yet available, and very few cases reporting kidney-transplanted patients treated with PD-1 inhibitors are available in the literature. Therefore, in this work, we review the published cases and suggest feasible approaches for renal transplant patients with advanced malignancy treated by a PD-1 inhibitor. Of the 22 cases we obtained, four patients maintained intact grafts without tumor progression after treatment with a PD-1 inhibitor. Among these patients, one maintained steroid dose before initiation of anti-PD1, two received immunosuppressive regimens with low-dose steroid and calcineurin inhibitor (CNI)-elimination with sirolimus before initiation of anti-PD-1 therapy, and one received combined anti-PD-1, anti-vascular endothelial growth factor (VEGF), and chemotherapy with unchanged immunosuppressive regimens. mammalian target of rapamycin (mTOR) inhibitors and anti-VEGF may act as regulators of tumor-specific and allogenic T-cells. However, more studies are necessary to explore the optimal therapy and ensure the safety and efficacy of PD-1 inhibitors in kidney-transplanted patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, General & Internal

Association of early loss of primary functional patency of arteriovenous access with mortality in incident hemodialysis patients A nationwide population-based observational study

Chung-Kuan Wu, Chia-Hsun Lin, Chih-Cheng Hsu, Der-Cherng Tarng, Chew-Teng Kor, Yi-Chun Chen, Chia-Lin Wu, Chia-Chu Chang

MEDICINE (2018)

Article Chemistry, Multidisciplinary

Organic Electrochemical Transistors/SERS-Active Hybrid Biosensors Featuring Gold Nanoparticles Immobilized on Thiol-Functionalized PEDOT Films

Jia-An Chou, Chieh-Lin Chung, Po-Cheng Ho, Chun-Hao Luo, Yu-Han Tsai, Chung-Kuan Wu, Chiung-Wen Kuo, Yu-Sheng Hsiao, Hsiao-hua Yu, Peilin Chen

FRONTIERS IN CHEMISTRY (2019)

Review Cardiac & Cardiovascular Systems

Comparison of Percutaneous Transluminal Angioplasty with Stenting for Treatment of Central Venous Stenosis or Occlusion in Hemodialysis Patients: A Systematic Review and Meta-analysis

Tien-Yu Wu, Chung-Kuan Wu, Yen-Yang Chen, Chia-Hsun Lin

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2020)

Article Surgery

Outcomes of the Gore Excluder abdominal aortic aneurysm leg endoprosthesis for treatment of central vein stenosis or occlusion in patients with chronic hemodialysis

Yen-Yang Chen, Chung-Kuan Wu, Chia-Hsun Lin

JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS (2020)

Article Medicine, General & Internal

Renal Tubular TRPA1 as a Risk Factor for Recovery of Renal Function from Acute Tubular Necrosis

Chung-Kuan Wu, Chia-Lin Wu, Tzu-Cheng Su, Yu Ru Kou, Chew-Teng Kor, Tzong-Shyuan Lee, Der-Cherng Tarng

JOURNAL OF CLINICAL MEDICINE (2019)

Article Medicine, General & Internal

Early Chronic Kidney Disease Care Programme delays kidney function deterioration in patients with stage I-IIIa chronic kidney disease: an observational cohort study in Taiwan

Shu-Fen Niu, Chung-Kuan Wu, Nai-Chen Chuang, Ya-Bei Yang, Tzu-Hao Chang

Summary: The Early CKD Care Programme was found to be an independent protective factor against progression of early CKD in patients with stage I-IIIa. The programme participants showed lower risk of progression to stage IIIb compared to non-participants, even with higher comorbidities. Furthermore, the programme was especially beneficial for patients with CKD stage IIIa in preventing progression to stage IIIb.

BMJ OPEN (2021)

Article Biochemistry & Molecular Biology

Renal Tubular Epithelial TRPA1 Acts as An Oxidative Stress Sensor to Mediate Ischemia-Reperfusion-Induced Kidney Injury through MAPKs/NF-κB Signaling

Chung-Kuan Wu, Chia-Lin Wu, Tzong-Shyuan Lee, Yu Ru Kou, Der-Cherng Tarng

Summary: The study found that TRPA1 plays a role in AKI by sensing oxidative stress and regulating inflammation in renal tubular cells. TRPA1 expression increased in patients with AKI and in a mouse model of IR-induced injury, highlighting its importance in kidney injury. In vitro experiments showed that TRPA1 activation by ROS under hypoxia-reoxygenation injury conditions led to increased intracellular Ca2+ level and activation of inflammatory signaling pathways.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Role of TRPA1 in Tissue Damage and Kidney Disease

Chung-Kuan Wu, Ji-Fan Lin, Tzong-Shyuan Lee, Yu Ru Kou, Der-Cherng Tarng

Summary: TRPA1 plays dual roles in sensory neurons and non-neuronal cells, promoting tissue repair, clearing harmful stimuli, and inducing protective responses, while also potentially contributing to disease progression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Dermatology

Epidemiology of dermatologic disease in Palau: a cross-sectional study in the national public and community health service

Wan-Ting J. Lee, Chien-Chang Lee, Chung-Kuan Wu, Ching-Hwa Lin, Te-Yu Lo, Chieh-Chen Huang, Sam L. Kahler, Haw-Yueh Thong

Summary: This study provides preliminary epidemiologic data on the prevalence of dermatologic disease in the adult population of Palau. It highlights the heavy burden of dermatologic disease in Palau compared to other Oceanic nations, emphasizing the need for ongoing dermatology services to achieve health equality.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2022)

Article Medicine, General & Internal

Factors affecting arteriovenous access patency after percutaneous transluminal angioplasty in chronic haemodialysis patients under vascular access monitoring and surveillance: a single-centre observational study

Chung-Kuan Wu, Der-Cherng Tarng, Chih-Yu Yang, Jyh-Gang Leu, Chia-Hsun Lin

Summary: The study found that AVG access type, acute myocardial infarction, and high ferritin levels are risk factors for re-intervention post-PTA. These findings may be useful in the development of prophylactic strategies for monitoring VA function and tailoring surveillance programs for these dialysis patients.

BMJ OPEN (2022)

Article Rehabilitation

Comparison of corticosteroid injection, physiotherapy and combined treatment for patients with chronic subacromial bursitis - A randomised controlled trial

Lin-Fen Hsieh, Ying-Chen Kuo, Yu-Hao Huang, Ya-Fang Liu, Tien-Lee Hsieh

Summary: This study aimed to investigate whether the combination of corticosteroid subdeltoid injections and physiotherapy was more effective than either treatment alone in patients with chronic subacromial bursitis. The results showed that both corticosteroid injection and combined treatment were superior to physiotherapy alone in terms of shoulder flexion and treatment effect. However, the physiotherapy group had the lowest recurrence rate.

CLINICAL REHABILITATION (2023)

Article Dermatology

Dermatoses in children in the Republic of Palau

Haw-Yueh Thong, Chung-Kuan Wu, Ching-Hwa Lin, Te-Yu Lo, Chieh-Chen Huang

DERMATOLOGICA SINICA (2020)

No Data Available